Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tuberculosis (TB) Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tuberculosis (TB) Diagnostics market.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Key Features:
The report on Tuberculosis (TB) Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tuberculosis (TB) Diagnostics market. It may include historical data, market segmentation by Type (e.g., Culture-Based Diagnostics, Sputum Smear Microscopy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tuberculosis (TB) Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tuberculosis (TB) Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tuberculosis (TB) Diagnostics industry. This include advancements in Tuberculosis (TB) Diagnostics technology, Tuberculosis (TB) Diagnostics new entrants, Tuberculosis (TB) Diagnostics new investment, and other innovations that are shaping the future of Tuberculosis (TB) Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tuberculosis (TB) Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Tuberculosis (TB) Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tuberculosis (TB) Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tuberculosis (TB) Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tuberculosis (TB) Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tuberculosis (TB) Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tuberculosis (TB) Diagnostics market.
Market Segmentation:
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tuberculosis (TB) Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tuberculosis (TB) Diagnostics market.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Key Features:
The report on Tuberculosis (TB) Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tuberculosis (TB) Diagnostics market. It may include historical data, market segmentation by Type (e.g., Culture-Based Diagnostics, Sputum Smear Microscopy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tuberculosis (TB) Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tuberculosis (TB) Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tuberculosis (TB) Diagnostics industry. This include advancements in Tuberculosis (TB) Diagnostics technology, Tuberculosis (TB) Diagnostics new entrants, Tuberculosis (TB) Diagnostics new investment, and other innovations that are shaping the future of Tuberculosis (TB) Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tuberculosis (TB) Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Tuberculosis (TB) Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tuberculosis (TB) Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tuberculosis (TB) Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tuberculosis (TB) Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tuberculosis (TB) Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tuberculosis (TB) Diagnostics market.
Market Segmentation:
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis (TB) Diagnostics Market Size 2019-2030
2.1.2 Tuberculosis (TB) Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tuberculosis (TB) Diagnostics Segment by Type
2.2.1 Culture-Based Diagnostics
2.2.2 Sputum Smear Microscopy
2.2.3 Rapid Molecular Diagnostics
2.2.4 Others
2.3 Tuberculosis (TB) Diagnostics Market Size by Type
2.3.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Tuberculosis (TB) Diagnostics Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals
2.5 Tuberculosis (TB) Diagnostics Market Size by Application
2.5.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Tuberculosis (TB) Diagnostics Market Size Market Share by Players
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS (TB) DIAGNOSTICS BY REGIONS
4.1 Tuberculosis (TB) Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.3 APAC Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.4 Europe Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
5.2 Americas Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
5.3 Americas Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
6.2 APAC Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
6.3 APAC Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics by Country (2019-2024)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis (TB) Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET FORECAST
10.1 Global Tuberculosis (TB) Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Tuberculosis (TB) Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Tuberculosis (TB) Diagnostics Forecast
10.1.3 APAC Tuberculosis (TB) Diagnostics Forecast
10.1.4 Europe Tuberculosis (TB) Diagnostics Forecast
10.1.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast
10.2 Americas Tuberculosis (TB) Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Tuberculosis (TB) Diagnostics Market Forecast
10.2.2 Canada Tuberculosis (TB) Diagnostics Market Forecast
10.2.3 Mexico Tuberculosis (TB) Diagnostics Market Forecast
10.2.4 Brazil Tuberculosis (TB) Diagnostics Market Forecast
10.3 APAC Tuberculosis (TB) Diagnostics Forecast by Region (2025-2030)
10.3.1 China Tuberculosis (TB) Diagnostics Market Forecast
10.3.2 Japan Tuberculosis (TB) Diagnostics Market Forecast
10.3.3 Korea Tuberculosis (TB) Diagnostics Market Forecast
10.3.4 Southeast Asia Tuberculosis (TB) Diagnostics Market Forecast
10.3.5 India Tuberculosis (TB) Diagnostics Market Forecast
10.3.6 Australia Tuberculosis (TB) Diagnostics Market Forecast
10.4 Europe Tuberculosis (TB) Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Tuberculosis (TB) Diagnostics Market Forecast
10.4.2 France Tuberculosis (TB) Diagnostics Market Forecast
10.4.3 UK Tuberculosis (TB) Diagnostics Market Forecast
10.4.4 Italy Tuberculosis (TB) Diagnostics Market Forecast
10.4.5 Russia Tuberculosis (TB) Diagnostics Market Forecast
10.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Tuberculosis (TB) Diagnostics Market Forecast
10.5.2 South Africa Tuberculosis (TB) Diagnostics Market Forecast
10.5.3 Israel Tuberculosis (TB) Diagnostics Market Forecast
10.5.4 Turkey Tuberculosis (TB) Diagnostics Market Forecast
10.5.5 GCC Countries Tuberculosis (TB) Diagnostics Market Forecast
10.6 Global Tuberculosis (TB) Diagnostics Forecast by Type (2025-2030)
10.7 Global Tuberculosis (TB) Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Danaher
11.1.1 Danaher Company Information
11.1.2 Danaher Tuberculosis (TB) Diagnostics Product Offered
11.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Danaher Main Business Overview
11.1.5 Danaher Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Tuberculosis (TB) Diagnostics Product Offered
11.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Tuberculosis (TB) Diagnostics Product Offered
11.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Tuberculosis (TB) Diagnostics Product Offered
11.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Hologic
11.6.1 Hologic Company Information
11.6.2 Hologic Tuberculosis (TB) Diagnostics Product Offered
11.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hologic Main Business Overview
11.6.5 Hologic Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Offered
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 BioMerieux
11.8.1 BioMerieux Company Information
11.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Offered
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMerieux Main Business Overview
11.8.5 BioMerieux Latest Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Information
11.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hain Lifescience Main Business Overview
11.9.5 Hain Lifescience Latest Developments
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Information
11.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Oxford Immunotec Main Business Overview
11.10.5 Oxford Immunotec Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis (TB) Diagnostics Market Size 2019-2030
2.1.2 Tuberculosis (TB) Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tuberculosis (TB) Diagnostics Segment by Type
2.2.1 Culture-Based Diagnostics
2.2.2 Sputum Smear Microscopy
2.2.3 Rapid Molecular Diagnostics
2.2.4 Others
2.3 Tuberculosis (TB) Diagnostics Market Size by Type
2.3.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Tuberculosis (TB) Diagnostics Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals
2.5 Tuberculosis (TB) Diagnostics Market Size by Application
2.5.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Tuberculosis (TB) Diagnostics Market Size Market Share by Players
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS (TB) DIAGNOSTICS BY REGIONS
4.1 Tuberculosis (TB) Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.3 APAC Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.4 Europe Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
5.2 Americas Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
5.3 Americas Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
6.2 APAC Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
6.3 APAC Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics by Country (2019-2024)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis (TB) Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUBERCULOSIS (TB) DIAGNOSTICS MARKET FORECAST
10.1 Global Tuberculosis (TB) Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Tuberculosis (TB) Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Tuberculosis (TB) Diagnostics Forecast
10.1.3 APAC Tuberculosis (TB) Diagnostics Forecast
10.1.4 Europe Tuberculosis (TB) Diagnostics Forecast
10.1.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast
10.2 Americas Tuberculosis (TB) Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Tuberculosis (TB) Diagnostics Market Forecast
10.2.2 Canada Tuberculosis (TB) Diagnostics Market Forecast
10.2.3 Mexico Tuberculosis (TB) Diagnostics Market Forecast
10.2.4 Brazil Tuberculosis (TB) Diagnostics Market Forecast
10.3 APAC Tuberculosis (TB) Diagnostics Forecast by Region (2025-2030)
10.3.1 China Tuberculosis (TB) Diagnostics Market Forecast
10.3.2 Japan Tuberculosis (TB) Diagnostics Market Forecast
10.3.3 Korea Tuberculosis (TB) Diagnostics Market Forecast
10.3.4 Southeast Asia Tuberculosis (TB) Diagnostics Market Forecast
10.3.5 India Tuberculosis (TB) Diagnostics Market Forecast
10.3.6 Australia Tuberculosis (TB) Diagnostics Market Forecast
10.4 Europe Tuberculosis (TB) Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Tuberculosis (TB) Diagnostics Market Forecast
10.4.2 France Tuberculosis (TB) Diagnostics Market Forecast
10.4.3 UK Tuberculosis (TB) Diagnostics Market Forecast
10.4.4 Italy Tuberculosis (TB) Diagnostics Market Forecast
10.4.5 Russia Tuberculosis (TB) Diagnostics Market Forecast
10.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Tuberculosis (TB) Diagnostics Market Forecast
10.5.2 South Africa Tuberculosis (TB) Diagnostics Market Forecast
10.5.3 Israel Tuberculosis (TB) Diagnostics Market Forecast
10.5.4 Turkey Tuberculosis (TB) Diagnostics Market Forecast
10.5.5 GCC Countries Tuberculosis (TB) Diagnostics Market Forecast
10.6 Global Tuberculosis (TB) Diagnostics Forecast by Type (2025-2030)
10.7 Global Tuberculosis (TB) Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Danaher
11.1.1 Danaher Company Information
11.1.2 Danaher Tuberculosis (TB) Diagnostics Product Offered
11.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Danaher Main Business Overview
11.1.5 Danaher Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Tuberculosis (TB) Diagnostics Product Offered
11.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Tuberculosis (TB) Diagnostics Product Offered
11.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Tuberculosis (TB) Diagnostics Product Offered
11.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Hologic
11.6.1 Hologic Company Information
11.6.2 Hologic Tuberculosis (TB) Diagnostics Product Offered
11.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hologic Main Business Overview
11.6.5 Hologic Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Offered
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 BioMerieux
11.8.1 BioMerieux Company Information
11.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Offered
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMerieux Main Business Overview
11.8.5 BioMerieux Latest Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Information
11.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hain Lifescience Main Business Overview
11.9.5 Hain Lifescience Latest Developments
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Information
11.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Oxford Immunotec Main Business Overview
11.10.5 Oxford Immunotec Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tuberculosis (TB) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Culture-Based Diagnostics
Table 3. Major Players of Sputum Smear Microscopy
Table 4. Major Players of Rapid Molecular Diagnostics
Table 5. Major Players of Others
Table 6. Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 9. Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 12. Global Tuberculosis (TB) Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player (2019-2024)
Table 14. Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
Table 15. Tuberculosis (TB) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Tuberculosis (TB) Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Regions (2019-2024)
Table 20. Global Tuberculosis (TB) Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2019-2024)
Table 24. Americas Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 26. Americas Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 28. APAC Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Table 30. APAC Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 32. APAC Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 34. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2019-2024)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Tuberculosis (TB) Diagnostics
Table 47. Key Market Challenges & Risks of Tuberculosis (TB) Diagnostics
Table 48. Key Industry Trends of Tuberculosis (TB) Diagnostics
Table 49. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Danaher Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 54. Danaher Tuberculosis (TB) Diagnostics Product Offered
Table 55. Danaher Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Danaher Main Business
Table 57. Danaher Latest Developments
Table 58. Roche Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 59. Roche Tuberculosis (TB) Diagnostics Product Offered
Table 60. Roche Main Business
Table 61. Roche Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. BD Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 69. BD Tuberculosis (TB) Diagnostics Product Offered
Table 70. BD Main Business
Table 71. BD Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. BD Latest Developments
Table 73. Abbott Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 74. Abbott Tuberculosis (TB) Diagnostics Product Offered
Table 75. Abbott Main Business
Table 76. Abbott Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Abbott Latest Developments
Table 78. Hologic Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 79. Hologic Tuberculosis (TB) Diagnostics Product Offered
Table 80. Hologic Main Business
Table 81. Hologic Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Hologic Latest Developments
Table 83. Qiagen Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 84. Qiagen Tuberculosis (TB) Diagnostics Product Offered
Table 85. Qiagen Main Business
Table 86. Qiagen Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Qiagen Latest Developments
Table 88. BioMerieux Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 89. BioMerieux Tuberculosis (TB) Diagnostics Product Offered
Table 90. BioMerieux Main Business
Table 91. BioMerieux Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BioMerieux Latest Developments
Table 93. Hain Lifescience Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 94. Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
Table 95. Hain Lifescience Main Business
Table 96. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Hain Lifescience Latest Developments
Table 98. Oxford Immunotec Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 99. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
Table 100. Oxford Immunotec Main Business
Table 101. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Oxford Immunotec Latest Developments
Table 1. Tuberculosis (TB) Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Culture-Based Diagnostics
Table 3. Major Players of Sputum Smear Microscopy
Table 4. Major Players of Rapid Molecular Diagnostics
Table 5. Major Players of Others
Table 6. Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 9. Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 12. Global Tuberculosis (TB) Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player (2019-2024)
Table 14. Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
Table 15. Tuberculosis (TB) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Tuberculosis (TB) Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Regions (2019-2024)
Table 20. Global Tuberculosis (TB) Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2019-2024)
Table 24. Americas Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 26. Americas Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 28. APAC Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Table 30. APAC Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 32. APAC Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 34. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country (2019-2024)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Tuberculosis (TB) Diagnostics
Table 47. Key Market Challenges & Risks of Tuberculosis (TB) Diagnostics
Table 48. Key Industry Trends of Tuberculosis (TB) Diagnostics
Table 49. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Danaher Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 54. Danaher Tuberculosis (TB) Diagnostics Product Offered
Table 55. Danaher Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Danaher Main Business
Table 57. Danaher Latest Developments
Table 58. Roche Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 59. Roche Tuberculosis (TB) Diagnostics Product Offered
Table 60. Roche Main Business
Table 61. Roche Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. BD Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 69. BD Tuberculosis (TB) Diagnostics Product Offered
Table 70. BD Main Business
Table 71. BD Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. BD Latest Developments
Table 73. Abbott Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 74. Abbott Tuberculosis (TB) Diagnostics Product Offered
Table 75. Abbott Main Business
Table 76. Abbott Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Abbott Latest Developments
Table 78. Hologic Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 79. Hologic Tuberculosis (TB) Diagnostics Product Offered
Table 80. Hologic Main Business
Table 81. Hologic Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Hologic Latest Developments
Table 83. Qiagen Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 84. Qiagen Tuberculosis (TB) Diagnostics Product Offered
Table 85. Qiagen Main Business
Table 86. Qiagen Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Qiagen Latest Developments
Table 88. BioMerieux Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 89. BioMerieux Tuberculosis (TB) Diagnostics Product Offered
Table 90. BioMerieux Main Business
Table 91. BioMerieux Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BioMerieux Latest Developments
Table 93. Hain Lifescience Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 94. Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
Table 95. Hain Lifescience Main Business
Table 96. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Hain Lifescience Latest Developments
Table 98. Oxford Immunotec Details, Company Type, Tuberculosis (TB) Diagnostics Area Served and Its Competitors
Table 99. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
Table 100. Oxford Immunotec Main Business
Table 101. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Oxford Immunotec Latest Developments
LIST OF FIGURES
Figure 1. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tuberculosis (TB) Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type in 2023
Figure 10. Tuberculosis (TB) Diagnostics in Diagnostic Laboratories
Figure 11. Global Tuberculosis (TB) Diagnostics Market: Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 12. Tuberculosis (TB) Diagnostics in Hospitals
Figure 13. Global Tuberculosis (TB) Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application in 2023
Figure 15. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player in 2023
Figure 16. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Tuberculosis (TB) Diagnostics Value Market Share by Country in 2023
Figure 22. United States Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region in 2023
Figure 27. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Type in 2023
Figure 28. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Application in 2023
Figure 29. China Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country in 2023
Figure 36. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. United States Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. China Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. India Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. France Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. UK Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tuberculosis (TB) Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Tuberculosis (TB) Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type in 2023
Figure 10. Tuberculosis (TB) Diagnostics in Diagnostic Laboratories
Figure 11. Global Tuberculosis (TB) Diagnostics Market: Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 12. Tuberculosis (TB) Diagnostics in Hospitals
Figure 13. Global Tuberculosis (TB) Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application in 2023
Figure 15. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player in 2023
Figure 16. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Tuberculosis (TB) Diagnostics Value Market Share by Country in 2023
Figure 22. United States Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Region in 2023
Figure 27. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Type in 2023
Figure 28. APAC Tuberculosis (TB) Diagnostics Market Size Market Share by Application in 2023
Figure 29. China Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Country in 2023
Figure 36. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Tuberculosis (TB) Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. United States Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. China Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. India Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. France Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. UK Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Tuberculosis (TB) Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Tuberculosis (TB) Diagnostics Market Size Market Share Forecast by Application (2025-2030)
